The study, available here ( http://offers.covisint.com/Brief.html ) was done by Porter Research, which conducted interviews with 50 qualified, mostly C-level participants. Study results are "directional or observational," and respondents were informed that Covisint sponsored the study.
Covisint healthcare meets healthcare organizations where they are in their technology adoption, enabling them to mature into a fully functioning, clinically integrated community with multi-system integrations and advanced analytics. Covisint delivers high value to accountable care stakeholders by supporting a comprehensive health information technology roadmap that fills the gaps left by existing technology investments. Covisint's agnostic platform enables the free, secure flow of information with the customer in full control, helping healthcare providers avoid being reliant upon one vendor, payer or HIE. And, Covisint Healthcare works with or without an existing EMR system.
Covisint, a Compuware Company
Covisint provides the leading cloud engagement platform for creating and enabling new mission-critical external business processes. Our solutions enable organizations to connect, engage, and collaborate with the critical external audiences that define their success--including customers, business partners and suppliers. Covisint allows its clients to establish a secure, reliable, integrated presence in the cloud, and it provides the kind of engaging information experiences that people everywhere have come to expect. Learn more at www.covisint.com .Follow us: http://www.compuware.com . Follow us on:
CONTACT: Media Contact Doug Anter, Public Relations Manager, Covisint, email@example.com, 313-227-0127 For Sales and Marketing Information Compuware Corporation, One Campus Martius, Detroit, MI 48226, 800-521-9353, http://www.compuware.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts